Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Donatelli

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Physical Therapy|February 1, 1994
Effects of three different posting methods on controlling abnormal subtalar pronationM A Johanson, R Donatelli, M J Wooden, et al.
The Journal of Orthopaedic and Sports Physical Therapy|September 20, 2000
Assessment of shoulder strength in professional baseball pitchersR Donatelli, T S Ellenbecker, S R Ekedahl, et al.
The Journal of Orthopaedic and Sports Physical Therapy|June 17, 1999
Relationship between static and dynamic foot postures in professional baseball playersR Donatelli, M Wooden, S R Ekedahl, et al.
Bioorganic & Medicinal Chemistry Letters|October 2, 2007
Potent 2'-aminoanilide inhibitors of cFMS as potential anti-inflammatory agentsRaymond J Patch, Benjamin M Brandt, Davoud Asgari, et al.
Journal of Medicinal Chemistry|February 6, 2009
Pyrido[2,3-d]pyrimidin-5-ones: a novel class of antiinflammatory macrophage colony-stimulating factor-1 receptor inhibitorsHui Huang, Daniel A Hutta, James M Rinker, et al.
Journal of Medicinal Chemistry|November 2, 2011
Optimization of a potent class of arylamide colony-stimulating factor-1 receptor inhibitors leading to anti-inflammatory clinical candidate 4-cyano-N-[2-(1-cyclohexen-1-yl)-4-[1-[(dimethylamino)acetyl]-4-piperidinyl]phenyl]-1H-imidazole-2-carboxamide (JNJ-28312141)Carl R Illig, Carl L Manthey, Mark J Wall, et al.
Bioorganic & Medicinal Chemistry Letters|October 22, 2013
Enhancement of kinase selectivity in a potent class of arylamide FMS inhibitorsCarl R Illig, Carl L Manthey, Sanath K Meegalla, et al.
Bioorganic & Medicinal Chemistry Letters|February 22, 2008
Synthesis and evaluation of novel 3,4,6-substituted 2-quinolones as FMS kinase inhibitorsMark J Wall, Jinsheng Chen, Sanath Meegalla, et al.
Molecular Cancer Therapeutics|January 25, 2006
Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivoHolly K Koblish, Shuyuan Zhao, Carol F Franks, et al.
Molecular Cancer Therapeutics|November 6, 2009
JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemiaCarl L Manthey, Dana L Johnson, Carl R Illig, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Physical Therapy|February 1, 1994
Effects of three different posting methods on controlling abnormal subtalar pronationM A Johanson, R Donatelli, M J Wooden, et al.
The Journal of Orthopaedic and Sports Physical Therapy|September 20, 2000
Assessment of shoulder strength in professional baseball pitchersR Donatelli, T S Ellenbecker, S R Ekedahl, et al.
The Journal of Orthopaedic and Sports Physical Therapy|June 17, 1999
Relationship between static and dynamic foot postures in professional baseball playersR Donatelli, M Wooden, S R Ekedahl, et al.
Bioorganic & Medicinal Chemistry Letters|October 2, 2007
Potent 2'-aminoanilide inhibitors of cFMS as potential anti-inflammatory agentsRaymond J Patch, Benjamin M Brandt, Davoud Asgari, et al.
Journal of Medicinal Chemistry|February 6, 2009
Pyrido[2,3-d]pyrimidin-5-ones: a novel class of antiinflammatory macrophage colony-stimulating factor-1 receptor inhibitorsHui Huang, Daniel A Hutta, James M Rinker, et al.
Journal of Medicinal Chemistry|November 2, 2011
Optimization of a potent class of arylamide colony-stimulating factor-1 receptor inhibitors leading to anti-inflammatory clinical candidate 4-cyano-N-[2-(1-cyclohexen-1-yl)-4-[1-[(dimethylamino)acetyl]-4-piperidinyl]phenyl]-1H-imidazole-2-carboxamide (JNJ-28312141)Carl R Illig, Carl L Manthey, Mark J Wall, et al.
Bioorganic & Medicinal Chemistry Letters|October 22, 2013
Enhancement of kinase selectivity in a potent class of arylamide FMS inhibitorsCarl R Illig, Carl L Manthey, Sanath K Meegalla, et al.
Bioorganic & Medicinal Chemistry Letters|February 22, 2008
Synthesis and evaluation of novel 3,4,6-substituted 2-quinolones as FMS kinase inhibitorsMark J Wall, Jinsheng Chen, Sanath Meegalla, et al.
Molecular Cancer Therapeutics|January 25, 2006
Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivoHolly K Koblish, Shuyuan Zhao, Carol F Franks, et al.
Molecular Cancer Therapeutics|November 6, 2009
JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemiaCarl L Manthey, Dana L Johnson, Carl R Illig, et al.
Pageof 2